Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Контрацептив с антиандрогенным и антиминералокортикоидным свойствами
Контрацептив с антиандрогенным и антиминералокортикоидным свойствами
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Rosenbaum P, Schmidt W, Helmerhorst FM et al. Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol. Eur J Contracept Reprod Health Care 2000; 5: 16–24.
2. Fuhrmann U, Krattenmacher R, Slater EP, Fritzemaier KH. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996; 54: 243–51.
3. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996; 61: 166–71.
4. Resenbaum P, Schmidt W, Helmerhorst FM et al. Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol. Eur J Contracept Reprod Health Care 2000; 5: 16–24.
5. Kuhnz W, Blode H, Zimmermann H. Pharmacokinetics of exogenous natural and synthetics estrogens and antiestrogens. In: Oetter M, Schillinger E, eds. Handbook of experimental pharmacology. Vol. 135/II. Estrogens and antiestrogens. Berlin: Springer-Verlag, 1999; 261–322.
6. Oelkers WK, Foidart JM, Dombrovicz N et al. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenon, on the renin – aldosterone systems, body weight, blood pressure, glucose tolerance and lipid metabolism.J Clin Endocrinol Metab 1995; 80: 1816–21.
7. Oelkers WK, Schoneshofer M, Blumel A. Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone systems in man. J Clin Endocrinol Metab 1974; 39: 882–90.8. Прилепская В.Н., Межевитинова Е.А., Назарова и др. Материалы VI Российского форума "Мать и дитя", 2004.
2. Fuhrmann U, Krattenmacher R, Slater EP, Fritzemaier KH. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996; 54: 243–51.
3. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996; 61: 166–71.
4. Resenbaum P, Schmidt W, Helmerhorst FM et al. Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol. Eur J Contracept Reprod Health Care 2000; 5: 16–24.
5. Kuhnz W, Blode H, Zimmermann H. Pharmacokinetics of exogenous natural and synthetics estrogens and antiestrogens. In: Oetter M, Schillinger E, eds. Handbook of experimental pharmacology. Vol. 135/II. Estrogens and antiestrogens. Berlin: Springer-Verlag, 1999; 261–322.
6. Oelkers WK, Foidart JM, Dombrovicz N et al. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenon, on the renin – aldosterone systems, body weight, blood pressure, glucose tolerance and lipid metabolism.J Clin Endocrinol Metab 1995; 80: 1816–21.
7. Oelkers WK, Schoneshofer M, Blumel A. Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone systems in man. J Clin Endocrinol Metab 1974; 39: 882–90.8. Прилепская В.Н., Межевитинова Е.А., Назарова и др. Материалы VI Российского форума "Мать и дитя", 2004.
Авторы
Л.И.Острейкова
Научный центр акушерства, гинекологии и перинатологии (дир. – акад. РАМН, проф. В.И.Кулаков) РАМН, Москва
Научный центр акушерства, гинекологии и перинатологии (дир. – акад. РАМН, проф. В.И.Кулаков) РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.